Cellular and Molecular Life Sciences · 2019 · 43 citations · 25 references
MedicineCancer BiologyOncologyGene ExpressionMolecular OncologyNeuro-oncologyCancer TranscriptomicsMicrorna BiologyNoncoding Rna In CancerPediatric Cancer BiologyRna InterferenceTumor Suppressor GenesDruggable Target DiscoveryMicrorna Function In CancerMicrorna In CancerMicrorna ScreeningMicrorna TargetingMicrorna TherapeuticsMicrorna TherapyNoncoding Rna Therapeutics
Current therapies for most non-infectious diseases are directed at or affect functionality of the human translated genome, barely 2% of all genetic information. By contrast, the therapeutic potential of targeting the transcriptome, ~ 70% of the genome, remains largely unexplored. RNA therapeutics is an emerging field that widens the range of druggable targets and includes elements such as microRNA. Here, we sought to screen for microRNA with tumor-suppressive functions in neuroblastoma, an aggressive pediatric tumor of the sympathetic nervous system that requires the development of new therapies. We found miR-323a-5p and miR-342-5p to be capable of reducing cell proliferation in multiple neuroblastoma cell lines in vitro and in vivo, thereby providing a proof of concept for miRNA-based therapies for neuroblastoma. Furthermore, the combined inhibition of the direct identified targets such as CCND1, CHAF1A, INCENP and BCL-XL could reveal new vulnerabilities of high-risk neuroblastoma.
25
KEGG: Kyoto Encyclopedia of Genes and Genomes
Minoru Kanehisa · Nucleic Acids Research · 2000 · 39.2K citations · Full text
KEGG: Kyoto Encyclopedia of Genes and Genomes
Hiroyuki Ogata, Susumu Goto, Kazushige Sato et al. · Nucleic Acids Research · 1999 · 32.4K citations · Full text
Jiří Lukáš, Heiko Müller, Jiřina Bártková et al. · The Journal of Cell Biology · 1994 · 276 citations · Full text